IRS1 and Insulin resistance: Firstly, ceramide inhibits insulin signaling by inhibiting insulin-stimulated phosphorylation of insulin receptor substrate-1 [33,34] and blocking activation of protein kinase B [34,35,36], which stimulates the development of insulin resistance [37,38].